nodal metastases, final resection margin and the presence of vascular, and/or perineural invasion. A minor hepatectomy was defined as a hepatic resection of less than three Couinaud segments. Margin status was categorized as R0 for tumor negative resection margins, R1 for microscopically positive margins and R2 for macroscopically positive margins. Only patients undergoing surgery for histologically confirmed ICC were included in the study population; patients who did not undergo resection were excluded. Patients who underwent transplantation were also excluded. The respective institutional review boards of each participating institution approved this study.
| Included models
Seven frequently used postoperative nomograms and staging systems for resected ICC patients were selected for this study. The prognostic models included those proposed by Wang et al, 18 the AJCC TNM 7th edition, 11 Hyder et al, 13 Liver Cancer Study Group of Japan (LCSGJ), 14 the Society of Hepatobiliary Surgery Japan (SHPBSJ), 15 Okabayashi et al, 16 and Nathan et al, 17 which are summarized in Table 1 .
| Statistical analysis
Categorical variables were described as whole numbers and percentages while continuous variables were reported as medians with interquartile (IQR) range. Percentages for each variable were calculated based on available data, excluding missing values. were performed, as these models had a larger amount of missing data.
Since c-indices cannot be pooled using Rubin's rules, median and range values were provided. 19 The primary outcome of the study was overall survival (OS). The secondary outcome was disease-free survival (DFS). OS was calculated as the time from the date of surgery to the date of death or date of last available follow-up, while DFS was calculated from the date of surgery to the date of first-known radiographically or pathologically confirmed metastasis. Both survival estimates were determined using the KaplanMeier method. The log-rank test was used to compare the strata of the prognostic models. Cox regression was performed to evaluate the effect of well-known prognostic variables in this particular cohort of patients. Each of the variables included in the models Schoenfeld residuals were plotted, in order to evaluate if the proportional hazards assumption was not violated. A sub-analysis among the patients who had a mass-forming ICC was conducted for the SHPBSJ and
Okabayashi staging systems, because these staging systems were originally developed in cohorts of patients with mass-forming ICC. 15, 16 Model performance was assessed using Harrell's concordance index (c-index). The c-index provides the probability that, in a randomly selected pair of patients, in which one patient dies before the other, the patient who died first had the worse predicted outcome from the nomogram. Analyses were performed using SPSS 22.0 (IBM, New York) and R version 3.03 (http://www.r-project.org) with the rms package. All tests were two-sided and P < 0.05 defined statistical significance.
3 | RESULTS
| Cohort description
A total of 1054 patients who underwent resection for ICC and met the inclusion criteria were identified ( In the AJCC 7th staging schema, the majority of patients were allocated into stages I and II (n = 692, 72.2%). In the LCSGJ staging system, almost 6 out of every 10 patients were allocated in stage II (n = 607, 59.3%), which was identical to the allocation using the 
| Overall survival and disease free survival
After a median follow-up of 27 months, nearly half of patients were deceased (n = 521, 49.7%). Median OS was 37.7 months and 1-, 3-, and 5-year survival was 78.8%, 51.5%, and 39.3%, respectively. Recurrence of disease occurred in 454 (43.1%) patients during follow-up.
Median disease-free survival was 29.6 months and 1-, 3-, and 5-year DFS was 64.6%, 46.5%, and 44.4%, respectively. 
Components of the prognostic models of interest were evaluated separately for prognostic ability with regards to OS and DFS ( 
| Comparison of scoring systems
Data on the performance of the models regarding the OS prediction are presented in Table 4 and Fig. 1 ; the ability of the models to predict DFS is presented in Table 5 and for OS. The ability of the models to predict DFS is presented in Table 5 and In this study, we examined the ability of established nomograms and staging systems to predict OS and DFS in one of the largest Western cohorts of ICC to date. We quantified the predictive ability of each nomogram using Harrell's concordance index. Although the included prognostic models varied considerably, some variables were included in multiple models. Notably, vascular invasion, lymph node metastases, and number of lesions were included in all prognostic models. These risk factors had significant prognostic In order to improve the predictive ability of current and new prognostic models, new determinants of biological processes in the form of biomarkers will be needed. Biomakers such as CEA and CA19-9 have previously been correlated with tumor processes and clinical outcomes. 31, 32 Only the Wang nomogram, however, utilized these biomarkers in a prognostic model. The superior discriminating ability of the Wang nomogram may relate to the importance of these biomarkers in prognostic models. In addition, a recent meta-analysis identified several other immunohistochemistry biomarkers associated with ICC. 33 To this end, some investigators have proposed that a composite biomarker profile that combines clinical factors (CEA and CA19-9) with pathological biomarkers may improve the accuracy of prognostic models and guide treatment in patients with resected ICC. 34 The potential of this approach has been proven with the recent successes of biomarker based prediction in breast cancer and colorectal cancer. 35, 36 Results of the current study should be interpreted in the context of several limitations. The inclusion of multiple centers did not allow for the standardization of operative approach or treatment-based protocols.
The multi-center nature of the study does add to the generalizability, allowing the findings to be applied across a wide range of patient populations. Another limitation was the unavailability of preoperative values of CEA and CA19-9 in a number of patients. The lack of CEA and CA19-9 data were likely related to the varied clinical practice across centers, as well as the relatively recent identification of CEA and CA19-9
as important prognostic factors. These missing values were unlikely to change the conclusions of the study, as multiple imputation analysis led to the same results. Additionally, due to the small number of patients with a tumor morphology other than mass-forming ICC, we were unable to assess prognostic models for each morphology separately. Finally, not all patients underwent lymphadenectomy and therefore the "true" nodal status of these patients could not be determined. It is likely that a subset of these patients did indeed harbor occult nodal metastases.
In conclusion, while the Wang nomogram had the best discriminatory ability relative to OS and DFS, no staging system or nomogram demonstrated excellent prognostic discrimination. The most widely adopted AJCC staging for ICC performed reasonably compared with other prognostic models, although its overall discrimination was only modest-to-good. Further research into the optimization of ICC prognostic models, possibly with inclusion of specific biomarkers, is warranted.
